Chinese Journal of New Drugs Articles

Articles>Articles Overview

1Analysis on orphan drug security policy from the perspective of drug life cycle in ChinaYUAN Ni, ZHOU Na, ZHANG Hai-jun, LI Zheng, ZHANG Xu, WANG Yong1-5

2Relationship between regional level of pharmaceutical economic development and R&D capital investment in pharmaceutical manufacturing industry in ChinaLI Wan-ting, WANG Su, CHEN Yu-wen6-12

3Key points on direct distribution for national drug reference standardsGAO Zhi-feng, XIAO Xin-yue, CAO Li-mei, XIE Li-hua, JIANG Jing-yu, SHAO Jun-juan13-16

4Development of background data on repeated toxicity studies in juvenile SD ratsCHONG Li-ming, YANG Yang, CHEN Li-fen, XU Li, CHEN Ding-shi, WANG Zhong-hui, ZHOU Li, SUN Zu-yue17-24

5Development and validation of a cell-based reporter gene assay for bioactivity determination of anti-EpCAM+CD3 bispecific antibodyZHANG Hong-mei, ZHANG Feng, LIU Chun-yu, YU Chuan-fei, DUAN Mao-qin, CAO Jun-xia, HUANG Jing, WANG Kai-qin, GUO Xiao, WANG Lan25-34

6Countermeasures for drug clinical trial management under major public health emergenciesPENG Peng, YUAN Wei-an, HU Yi-hui, TANG Jie35-37

7Research progress of immune checkpoint inhibitor-induced acute kidney injuryWANG Long, JIN Rong, HAN Yi-xuan, WANG Juan, ZHU Ling-na38-42

8Determination of dexrabeprazole and levrabeprazole in human plasma by HPLC-MS/MS and its pharmacokinetic studyLI Xiang-hong, XIE Hai-tang, LIANG Da-hu, SUN Hua, ZHOU Li-xiang, DAI Min, YANG Bin, WANG Wei-jia, SHEN Jie, ZHAO Ya-nan43-49

9Investigation and research on the state of clinical trials during epidemic period of COVID-19ZHU Xiao-fang, DAI Jian, LIU Ling-ye, ZHU Jing-jing, LU Meng, WANG Lu-lu, ZHU Qing, WANG Jian50-54

10Ameliorative effect and mechanism of mosloflavone on hypobaric hypoxia-induced heart damage in miceLIU Rui, SHAO Jin, ZHAO Tong, MA Hui-ping, HE Lei, JING Lin-lin55-61

11A combined simulation and experimental study of fluidized bed granulation for traditional Chinese medicine on the basis of computational fluid dynamicsZENG Jia, HUANG Ting, LIU Bin-bin, WANG Jia-miao, FENG Ling-lin, XUE Man, DU Ruo-fei, FENG Yi62-72

12Development of standard reagents for heparin anti-FⅩa and anti-FⅡa assayWANG Yue, LI Jing, WANG Xin-yu, LIU Li-sha, FAN Hui-hong73-79

13Taurodeoxycholic acid in the treatment of cholelithiasis:health technology assessment of effectiveness,safety and economicsLI Hui-bo, LIU Shuang, QIN You-fa, ZHAI Suo-di80-86

14Big data mining and analysis of security alert signals of olanzapineZHU Xiu-qing, HU Jin-qing, DENG Shu-hua, TAN Ya-qian, WANG Zhan-zhang, LU Hao-yang, NI Xiao-jia, LI Lu, ZHANG Ming, SHANG De-wei, WEN Yu-guan87-93